633 related articles for article (PubMed ID: 33608002)
21. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.
Kristensen SL; Jhund PS; Lee MMY; Køber L; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; McMurray JJV;
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):545-549. PubMed ID: 28948430
[TBL] [Abstract][Full Text] [Related]
23. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
[TBL] [Abstract][Full Text] [Related]
24. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters.
Schönbauer R; Duca F; Kammerlander AA; Aschauer S; Binder C; Zotter-Tufaro C; Koschutnik M; Fiedler L; Roithinger FX; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J
Eur J Clin Invest; 2020 Feb; 50(2):e13184. PubMed ID: 31732964
[TBL] [Abstract][Full Text] [Related]
25. Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction.
Maréchaux S; Six-Carpentier MM; Bouabdallaoui N; Montaigne D; Bauchart JJ; Mouquet F; Auffray JL; Le Tourneau T; Asseman P; LeJemtel TH; Ennezat PV
Heart Vessels; 2011 May; 26(3):313-20. PubMed ID: 21063875
[TBL] [Abstract][Full Text] [Related]
26. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
Zhang X; Lv X; Wang N; Yu S; Si J; Zhang Y; Cai M; Liu Y
Int J Cardiol; 2023 Aug; 385():34-40. PubMed ID: 37257517
[TBL] [Abstract][Full Text] [Related]
27. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
[TBL] [Abstract][Full Text] [Related]
28. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction.
Bolat I; Biteker M
Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867
[No Abstract] [Full Text] [Related]
29. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
[TBL] [Abstract][Full Text] [Related]
31. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
32. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
[TBL] [Abstract][Full Text] [Related]
33. Glycaemic control is a predictor of infection-related hospitalization on haemodialysis patients: Miyazaki Dialysis Cohort study (MID study).
Toida T; Sato Y; Nakagawa H; Komatsu H; Kikuchi M; Uezono S; Yamada K; Ishihara T; Hisanaga S; Kitamura K; Fujimoto S
Nephrology (Carlton); 2016 Mar; 21(3):236-40. PubMed ID: 26272229
[TBL] [Abstract][Full Text] [Related]
34. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
[TBL] [Abstract][Full Text] [Related]
35. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
36. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
[TBL] [Abstract][Full Text] [Related]
37. Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Shen L; Rørth R; Cosmi D; Kristensen SL; Petrie MC; Cosmi F; Latini R; Køber L; Anand IS; Carson PE; Granger CB; Komajda M; McKelvie RS; Solomon SD; Staszewsky L; Swedberg K; Huynh T; Zile MR; Jhund PS; McMurray JJV
Eur J Heart Fail; 2019 Aug; 21(8):974-984. PubMed ID: 31271255
[TBL] [Abstract][Full Text] [Related]
38. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
[TBL] [Abstract][Full Text] [Related]
39. Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.
Li F; Xu M; Fan Y; Wang Y; Song Y; Cui X; Fu M; Qi B; Han X; Zhou J; Ge J
Int J Cardiovasc Imaging; 2020 Apr; 36(4):671-689. PubMed ID: 31893323
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry.
Oikawa M; Yoshihisa A; Sato Y; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
Heart Vessels; 2020 Aug; 35(8):1087-1094. PubMed ID: 32193620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
